The Drug Enforcement Administration has told the public in writing when it can act. The notice of intent published in the Federal Register states that a temporary scheduling order placing 7-hydroxymitragynine above a specified threshold into Schedule I "will not be issued before August 5, 2026," and that the agency intends to issue it as soon as possible after that 30-day window closes.
As of today, 7-OH is not federally scheduled. The notice is not an order. The moment the DEA publishes the order, manufacturing, distributing, selling, and possessing covered 7-OH products becomes subject to the criminal, civil, and administrative provisions of the Controlled Substances Act, and the control lasts two years with a possible one-year extension.
